We examined temporal changes in the proportions of NK cells, T cells, CD8+ T cells, and NK cell subsets (CD56bright NK cells, CD56dimCD16- NK cells, CD56dimCD16+ NK cells) from admission to recovery in patients with mild and moderate COVID-19. This evidence concerns the gene CD8A and COVID-19.